INTRODUCTION
Cryptosporidium sp. are waterborne gastrointestinal protozoa that are ubiquitous in industrialized and developing countries. 1 In immunocompromised patients, Cryptosporidium can cause a severe and chronic diarrheal disease, whereas in immunocompetent patients, the disease follows a milder course and infection is often asymptomatic. [2] [3] [4] [5] In developing countries where access to clean water sources is limited, Cryptosporidium is one of the commonest causes of parasitic diarrheal disease in children less than five years of age. 6 These children often experience repeated infections with this parasite, 7, 8 leading to significant growth and developmental delays, [9] [10] [11] even in children with asymptomatic infection. 10 Cryptosporidiosis is also associated with malnutrition, [12] [13] [14] [15] [16] although cause and effect remain unclear. 17 Currently, treatment and prevention options are severely limited: there is no vaccine, and nitazoxanide, the only drug approved for treatment of cryptosporidiosis, 18 is ineffective in immunocompromised patients. 19 To develop better prevention and treatment strategies, it is important to characterize the immune responses to the parasite. Although the CD4+ immune response is essential for control of infection, 20 the serum antibody response to immunodominant antigens is correlated with protection from symptoms. 21 The humoral immune response has not been shown to directly participate in clearance of the parasite, and may well simply reflect development of protective cellular responses. However, several studies have found that patients with acquired immunodeficiency syndrome living in areas where cryptosporidiosis is endemic often have asymptomatic cryptosporidiosis even when severely immunosupressed. 22, 23 This observation suggests that in the absence of a robust CD4+ response, other immune responses such as antibodies or cytokines, may make a more significant contribution to protection from symptomatic infection.
There are two Cryptosporidium species ( C. hominis and C. parvum ) that cause most human infections. 24 Some antigens, such as the immunodominant Cp23 and gp15, are relatively conserved between the two species. 25, 26 A previous study from our group in this cohort of children using recombinant gp15 from both species as antigens in an enzyme-linked immunosorbent assay (ELISA) showed that both antigens induced serum antibody responses, and that there was crossreactivity between gp15 from C. hominis and C. parvum . 27 Similarly, the immunodominant p23 antigen induced significant serum antibody responses in case children compared with controls in this study (Borad AJ and others, unpublished data) . However, it is now recognized that Cryptosporidium also expresses antigens that are polymorphic between species and among isolates, most notably gp40, 24, 28, 29 and the more recently described Muc4 and Muc5. 30 These antigens have also been implicated in the processes of parasite attachment and invasion, suggesting that an immune response directed against these antigens might be critically important for protection. Gp40 is highly polymorphic among C. hominis and C. parvum isolates; to date, 20 alleles of this gene have been identified. 31, 32 A previous study from our group that investigated antibody responses to gp40 in children in southern India with cryptosporidiosis found that serum IgG responses to this antigen, although cross-reactive, are in part subtype specific. 33 Although there is only 58% identity between the C. hominis and C. parvum Muc4 alleles, there is little polymorphism at the Muc4 locus among C. hominis isolates, except for those isolates identified as human-adapted or anthroponotic C. parvum . 30 However, the nature and specificity of the immune response to Muc4 remain uncharacterized. To initiate studies on the immune response to Muc4 and the level of cross reactivity to the two protein isoforms, we expressed the C. hominis and C. parvum Muc4 proteins in Escherichia coli and examined antibody responses to both proteins in a cohort of children in Bangladesh infected with C. hominis .
MATERIALS AND METHODS

Cohort.
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Bangladesh in Dhaka, Bangladesh during May 2001-August 2002 and was designed as an age-matched case-control study. Children less than five years of age who had diarrhea when they came to the hospital were recruited. Forty-six children in whom microscopic examination identified Cryptosporidium oocysts in feces by modified acid-fast staining were enrolled as cases. An equal number of age-matched children with diarrhea, but with a negative stool examination results, were enrolled as controls. Subsequent evaluation by polymerase chain reaction (PCR) showed that seven of the controls had Cryptosporidium in feces. 35 Therefore, the study design was unmatched and the PCR-positive controls were reclassified as cases. Diarrhea was defined as three or more stools within a 24-hour period. A diarrheal episode was defined as diarrhea lasting 72 hours. The end of a diarrheal episode was defined as absence of diarrhea for 48 hours. Acute diarrhea was defined as a diarrheal episode lasting < 14 days. Persistent diarrhea was defined as a diarrheal episode lasting ≥ 14 days. Children with persistent diarrhea included those who had diarrhea for ≥ 14 days and those who continued to have diarrhea for ≥ 14 days during the follow-up period.
Serum samples were obtained at the time of enrollment and at follow-up three weeks later. Of the 53 cases, 34 returned for follow-up three weeks later, and of the 39 controls, 19 returned for follow-up. Informed consent was obtained from the parents of the children, and the study was approved by the Institutional Review Board of the International Center for Diarrheal Disease Research Center, Bangladesh. Serum samples were shipped on dry ice to Boston, Massachusetts and stored at -80°C. Approval for use of de-identified serum samples from children in the study was obtained from the Tufts Medical Center Institutional Review Board. For this study, we measured antibody levels in patients for whom we had initial and follow-up samples. Serum samples were available for all 34 cases, but for only 17 of the 19 controls.
We had previously sequenced the Muc4 gene from C. hominis and C. parvum isolates from this cohort and from C. parvum isolates from a cohort of children from India with cryptosporidiosis. 30 All C. hominis isolates had the published C. hominis Muc4 ( Ch Muc4) gene, whereas the C. parvum isolates had a unique Muc4 allele. All children whose serum samples were tested in this study were infected with C. hominis isolates, 35 and are presumed to carry the Ch Muc4 allele.
Expression of recombinant Cp Muc4 and Ch Muc4. The coding sequences of Ch Muc4 and C. parvum Muc4 ( Cp Muc4), without the 19 amino acid N-terminal signal sequence, were PCR amplified from C. hominis genomic DNA purified from the TU502 isolate (obtained from Dr. Saul Tzipori, Tufts Cummings School of Veterinary Medicine, North Grafton, MA) by using a gNOME DNA extraction kit (Qbiogene, Carlsbad, CA) and from plasmids containing the Cp Muc4 gene, 30 respectively. The primers incorporated the overhang sequences necessary for cloning into the pET46EkLIC vector (Invitrogen, Carlsbad, CA). Expression from this vector produces a fusion protein with an N-terminal 6X His tag that can be cleaved with enterokinase. After cloning and sequencing to verify correct insertion of the Muc4 sequences, the plasmids were used to transform E. coli BL21, and expression was induced with isopropyl β-D-1-thiogalactopyranoside. The fusion proteins were purified by using nickel affinity chromatography (NTA agarose; Qiagen, Valencia, CA) following the manufacturer's directions, and purification evaluated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie staining. The identity of the fusion proteins was confirmed by Western blotting with anti-Cp Muc4 rabbit serum samples as described. 30 The 6X His-tags were cleaved and separated from the recombinant (r)Muc4 proteins by using the enterokinase cleavage kit (Invitrogen), and identity of the rMuc4 proteins was confirmed by N-terminal sequencing by automated Edman degradation at the Tufts University Core Facility.
ELISA. The ELISA for detection of antibodies to r Cp Muc4 and r Ch Muc4 was conducted according to protocols used in our laboratory. 34 The optimal coating concentration of CpMuc4 and ChMuc4 was determined empirically using Cryptosporidium -negative (by gp15 ELISA and immunoblot), and -positive serum samples. Maxisorp 96-well plates (Nunc, Rochester, NY) were coated with 10 μg/mL of the recombinant proteins overnight at 4°C. Plates were washed in phosphatebuffered saline (PBS), 0.05% Tween 20 and blocked in 0.25% bovine serum albumin-PBS for either 2 hours at 37°C or overnight at 4°C, and used immediately. Serum samples were added to the wells at a 1:100 dilution in 0.25% bovine serum albumin-PBS and incubated for 2 hours at 37°C. All samples were tested in triplicate. The plates were washed three times and antibodies against Muc4 were detected with alkaline phosphatase-conjugated goat anti-human IgG, IgM, or IgA and p -nitrophenyl phosphate substrate. After 30 minutes, the absorbance at 405 nm (A 405 nm ) was measured with a BioRad Microplate Reader (Model 550; Bio-Rad Laboratories, Hercules, CA). The A 405 nm never exceeded 2.0 optical density units for any sample.
Statistical analysis. Samples were tested in triplicate. In those samples in which the triplicate values deviated from the other two samples by greater than 40%, the OD 405 was calculated as the mean of the two values that were in close agreement. To minimize effects of plate-to-plate variation, initial and follow-up serum samples of the same patient were always run on the same plate, and the same known Cryptosporidiumnegative and -positive serum samples were tested on each plate. To adjust for inter-plate variability, normalized ELISA units were calculated by dividing the A 405 nm of the sample by the A 405 nm of the positive control for that plate and multiplying by 100. This approach to standardization of ELISA values has been validated by using these same patient samples. 27 Statistical analysis was conduced by using PRISM version 4.03 (Graphpad, La Jolla, CA). Data was evaluated for normality by using the D'Agostino and Pearson omnibus normality test. Normally distributed data was compared by using the unpaired t -test to evaluate differences between cases and controls and by paired t -test to evaluate changes in antibody levels in initial and follow-up samples. For non-normally distributed data, the Mann-Whitney test and Wilcoxon matchedpairs test were used. Differences were considered significant at P < 0.05. Spearman correlations were used to test if there were significant correlations between antibody responses to the Muc4 proteins, and between the Muc4 proteins and total oocyst lysates.
RESULTS
Demographics.
The demographics of the subgroup of the cohort we have examined in this study are described in Table 1 . There were no statistically significant differences between cases and controls in age or nutritional status. The duration of diarrhea at presentation was significantly greater in cases compared with controls, and there were 12 cases with persistent diarrhea compared with none in the controls. Among cases, children with persistent diarrhea presented significantly later after the onset of diarrhea than those children with acute diarrhea. Children with acute diarrhea presented a median (interquartile range [IQR]) of 5 (3-7) days after onset of symptoms, whereas children with persistent diarrhea presented 14 (11.5-15.5) days after start of diarrhea ( P = 0.0001, by Mann-Whitney test). When a paired analysis was conducted to determine if there was a difference in IgG levels at the initial and follow-up time Antibody responses in children with acute diarrhea versus those with persistent diarrhea. The children in the cohort were divided into those with diarrhea that resolved within 14 days (acute), and those with diarrhea that persisted for ≥ 14 days (persistent). 34 All children in the control group had acute diarrhea. We compared the antibody response against Muc4 in the 22 cases with acute diarrhea and the 12 cases with persistent diarrhea. There were no significant differences in IgG or IgA responses to either antigen between children with acute diarrhea and children with persistent diarrhea. Children in both groups exhibited a strong trend to increased IgM levels to both antigens over time, but this increase did not achieve statistical significance ( P values: for children with acute diarrhea: antiCh Muc4 IgM P = 0.051, anti-Cp Muc4 IgM P = 0.073; for children with persistent diarrhea: anti-Ch Muc4 IgM P = 0.064, anti-Cp Muc4 IgM P = 0.052, by Wilcoxon matched-pairs test). Children with persistent diarrhea had significantly higher antiCh Muc4 IgM levels at presentation ( Figure 3 , upper panel) and continued to show higher levels at follow-up ( Figure 3 , lower panel). Higher IgM values in the persistent diarrhea group may reflect a more progressed immune response. There were no significant differences in anti-Cp Muc4 IgM levels between children with acute diarrhea and those with persistent diarrhea.
Expression of Ch
Correlation of antibody response to Ch Muc4 and Cp Muc4 with each other and with antibody responses to Ch and Cp oocyst lysates. Antibody responses to Ch Muc4 and Cp Muc4
were highly correlated with each other at initial and follow-up time points (Table 2 ) . This finding is likely attributable to epitopes shared between the two antigen isoforms. In previous studies in this cohort, antibody responses to C. par vum 34 and C. hominis oocyst lysates 27 were determined by using the same ELISA protocol. The antibody responses to Cp Muc4 were tested for a correlation with antibody responses to C. parvum oocyst lysate, and likewise antibodies to Ch Muc4 compared with the response to C. hominis oocyst lysate. There was a significant correlation between IgM responses to the Muc4 antigens and the respective oocyst lysates from each species at follow-up, and between Cp Muc4 and C. parvum oocysts at the initial time point ( Table 2 ). There were no correlations between IgA or IgG responses to oocyst lysate and Muc4 antigens.
DISCUSSION
Muc4 is a sporozoite surface antigen that localizes in the apical region of sporozoites and is implicated in the process of sporozoite invasion of host cells because of the ability of antibodies against Cp Muc4 to inhibit in vitro infection and because crude 30 and purified (O'Connor RM, unpublished data) native Cp Muc4 antigen binds to intestinal epithelial cells in vitro . 30 Additionally, the antigen is highly polymorphic between C. hominis and C. parvum , suggesting that Muc4 is subject to pressure from immune responses. In a previous study, we sequenced the Muc4 locus in a subset of isolates infecting the children in this cohort and found that all the isolates that typed as C. hominis carried the published Ch Muc4 allele, except for a few anthroponotic C. parvum IIm isolates that carried a unique Muc4 allele. 30 All the children included in this study were infected with C. hominis . This cohort provided an opportunity to investigate the antibody response to a homologous and heterologous antigen in children in whom the infecting isolate had been identified. The predominant response to the Muc4 antigens was of the IgM isotype. IgM to Ch Muc4 was significantly higher in cases than controls at follow-up, the change in anti-Ch Muc4 IgM was significantly greater in cases than in controls, and IgM to heterologous and homologous antigens was significantly greater at the follow-up than the initial time points in the cases ( Figure 2 ) . The IgM response to Muc4 also showed a correlation with the IgM response to oocyst lysate ( Table 2 ). An increasing IgM response is consistent with an initial infection, especially in the absence of an IgG response. 36, 37 Similarly, studies in human volunteers have documented a lack of IgG against Cryptosporidium after the primary infection, with IgG seroconversion occurring after secondary exposure. 36 However, previous studies on antibody responses to total C. parvum antigens and the immunodominant gp15 antigen in the same cohort of children showed a significant increase in serum IgG levels over the three-week follow-up period in cases compared with controls 27 , 33 and there was a significant increase in serum antibodies of all three isotypes to the p23 antigen in these children (Borad AJ and others, unpublished data). In Bedouin children, seroconversion increased with age, and IgG seroconversion occurred later than IgM and IgA. 37 In a longitudinal study of children in Peru with cryptosporidiosis, the magnitude of the antibody response increased with the number of infections, 38 and in general, the seropositivity of populations in disease-endemic areas increases with age. 39, 40 However, these studies examined the immune response to either oocyst lysates or immunodominant antigens, and Muc4 is not derived from an oocyst lysate and is not an immunodominant antigen. In this cohort, there was an IgG response to oocysts lysate over time, 34 and in human volunteers infected with C. hominis , an IgG response does develop after primary exposure, 41 unlike volunteers infected with C. parvum . 36 The development of a mature immune response to a less abundant, non-immunodominant antigen such as Muc4 may require multiple exposures. There also may be a poor cellular immune response to Muc4, especially after primary infection, so that IgG class switching is not supported. Many of the cases did not have a significant serum antibody response to either Muc4 antigen. The only study that investigated the immune response to a non-immunodominant Cryptosporidium antigen, thrombospondin-related adhesive protein, showed that a significant antibody response to this protein that occurred only in volunteers who developed diarrhea and were shedding oocysts. 42 Unfortunately, the responding antibody class was not identified. Similar observations have been made for the development of antibodies to the 27-kD (same as p23), 17-kD, (same as gp15) and 15-kD antigens, where the greatest antibody response was noted in those volunteers with symptomatic cryptosporidiosis. 43 Interestingly, both of these studies noted that persons with pre-existing antibodies to these antigens were more likely to be asymptomatic after challenge with C. parvum oocysts.
We also observed that the anti-Ch Muc4 IgM response was significantly higher in children with persistent cryptosporidial diarrhea at the initial time point, presumably from a longer exposure to the antigen because children with persistent diarrhea were enrolled in the study considerably later during the course of diarrhea than children with acute diarrhea. There was no difference in the change in anti-Ch Muc4 IgM between cases with acute diarrhea versus cases with persistent diarrhea. This finding is in contrast to antibody responses to total oocyst lysate, gp15, and p23 in the same children in whom the increase in serum IgA and/or IgM responses over the threeweek follow-up period were higher in children with acute diarrhea compared with those with persistent diarrhea 27 (Borad AJ and others, unpublished data). Because the children were recruited on the basis of symptoms, 34 we cannot determine if there is a protective effect of pre-existing antibodies against anti-Ch Muc4.
For all antibody isotypes, antibody response to Ch Muc4 was significantly correlated with that to Cp Muc4, indicating that at least some portion of the antibody response was directed against conserved epitopes. Because there is no data on the children's previous exposure to Cryptosporidium , an alternative possibility is that antibody to Cp Muc4 arose from previous infections, although this seems unlikely because zoonotic C. parvum infections were not observed in this cohort. 35 In terms of vaccine development, it is encouraging that there appears to be cross-reactivity between these antigens because Muc4 is highly divergent between species. 30 Studies using monoclonal antibodies to p23 and gp900 domains 1 and 5 have found antigenic differences between C. hominis and C. parvum antigens, even though these sequences are relatively conserved. 44 However, the identity of immunologically protective epitopes on any of these antigens is unknown.
Although there was no IgG response to homologous antigen, IgG to heterologous antigen was significantly higher in cases than controls at follow-up, and there was a trend toward an increase in IgG against Cp Muc4 over time in the cases ( P = 0.062). Similarly, levels of IgA against Cp Muc4 were significantly higher in cases than in controls at presentation, but there was no difference between groups in IgA levels to Ch Muc4. It is difficult to account for this observation. Because there was no difference in levels of IgG or IgA against Ch Muc4 between groups, these observations cannot be attributed to cross-reactive antibodies. BLAST searches of other apicomplexan genomes have not identified significant homology between Cp Muc4 and any other protein sequence, 30 making it unlikely that this is caused by cross-reactivity with antibodies to another pathogen. It is possible that the children with cryptosporidiosis had previous infections with C. parvum , although the demographic data did not identify any differences between cases and controls in contact with animals or water sources. 27 , 33 Characterization of antibody responses to Muc4 in children with cryptosporidiosis using a birth cohort study design might clarify these results.
There are several limitations in the study that must be taken into account when interpreting the data. Because children were recruited upon arriving at the hospital with diarrhea, there are no data on any previous Cryptosporidium infections, nor is there any information on the immune response in children with asymptomatic infections. Additionally, the initial sample was taken when the children came to the hospital at various times after the onset of diarrhea, resulting in the samples being taken at different points in the development of the immune response. The most important caveat is that the antigens used in this study are E. coli recombinant proteins that lack any post-translational modifications. Muc4 is predicted to be O-and N-glycosylated, 30 and although we have not found empirical evidence of glycosylation, the native antigen is 10 kD larger than the E. coli recombinant on SDS-PAGE gels (O'Connor R, unpublished data), which suggests significant post-translational modification. Thus, the immune response to the native antigens may be different than that observed in these studies, in which we only captured the response to protein epitopes. Future studies are planned using Toxoplasma gondii -expressed antigens, which carry similar glycotopes to native Cryptosporidium antigens. 45 We have shown in these studies that there is a humoral immune response to the Muc4 antigen in young children with cryptosporidiosis that consists primarily of IgM, and that some of this response is directed against conserved epitopes. Future studies using more appropriate antigens, and in other demographic groups such as adults positive for infection with human immunodeficiency virus, will provide more complete characterization of the immune response to this important antigen.
